CVS Health Corporation
CVS
$67.02
-$0.835-1.23%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 376.74B | 370.66B | 367.25B | 361.86B | 359.66B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 376.74B | 370.66B | 367.25B | 361.86B | 359.66B |
| Cost of Revenue | 325.72B | 321.41B | 316.53B | 309.85B | 307.32B |
| Gross Profit | 51.02B | 49.25B | 50.71B | 52.00B | 52.34B |
| SG&A Expenses | 41.59B | 41.13B | 41.05B | 40.32B | 39.79B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 367.31B | 362.54B | 357.59B | 350.17B | 347.11B |
| Operating Income | 9.43B | 8.12B | 9.66B | 11.69B | 12.56B |
| Income Before Tax | 7.19B | 6.15B | 6.73B | 9.64B | 9.87B |
| Income Tax Expenses | 1.94B | 1.56B | 1.72B | 2.44B | 2.52B |
| Earnings from Continuing Operations | 5.24K | 4.59K | 5.01K | 7.20K | 7.35K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 36.00M | 28.00M | 6.00M | -14.00M | -29.00M |
| Net Income | 5.28B | 4.61B | 5.02B | 7.19B | 7.32B |
| EBIT | 9.43B | 8.12B | 9.66B | 11.69B | 12.56B |
| EBITDA | 14.04B | 12.72B | 14.24B | 16.24B | 17.06B |
| EPS Basic | 4.19 | 3.67 | 3.95 | 5.64 | 5.71 |
| Normalized Basic EPS | 4.31 | 3.65 | 4.16 | 5.01 | 5.36 |
| EPS Diluted | 4.19 | 3.66 | 3.95 | 5.63 | 5.70 |
| Normalized Diluted EPS | 4.30 | 3.64 | 4.15 | 4.99 | 5.34 |
| Average Basic Shares Outstanding | 5.04B | 5.03B | 5.06B | 5.09B | 5.12B |
| Average Diluted Shares Outstanding | 5.04B | 5.05B | 5.08B | 5.11B | 5.14B |
| Dividend Per Share | 2.66 | 2.66 | 2.60 | 2.54 | 2.48 |
| Payout Ratio | 63.88% | 73.10% | 66.07% | 45.29% | 43.61% |